Literature DB >> 10980130

Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis.

S K Singhrao1, J W Neal, N K Rushmere, B P Morgan, P Gasque.   

Abstract

This study investigated the capacity of neurons and astrocytes to spontaneously activate the complement system and control activation by expressing complement regulators. Human fetal neurons spontaneously activated complement through the classical pathway in normal and immunoglobulin-deficient serum and C1q binding was noted on neurons but not on astrocytes. A strong staining for C4, C3b, iC3b neoepitope and C9 neoepitope was also found on neurons. More than 40% of human fetal neurons were lysed when exposed to normal human serum in the presence of a CD59-blocking antibody, whereas astrocytes were unaffected. Significant reduction in neuronal cell lysis was observed after the addition of soluble complement receptor 1 at 10 microg/ml. Fetal neurons were stained for CD59 and CD46 and were negative for CD55 and CD35. In contrast, fetal astrocytes were strongly stained for CD59, CD46, CD55, and were negative for CD35. This study demonstrates that human fetal neurons activate spontaneously the classical pathway of complement in an antibody-independent manner to assemble the cytolytic membrane attack complex on their membranes, whereas astrocytes are unaffected. One reason for the susceptibility of neurons to complement-mediated damage in vivo may reside in their poor capacity to control complement activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10980130      PMCID: PMC1885712          DOI: 10.1016/S0002-9440(10)64604-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  60 in total

1.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

2.  Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody.

Authors:  D R Wren; M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 3.  Complement regulation.

Authors:  S Meri; H Jarva
Journal:  Vox Sang       Date:  1998       Impact factor: 2.144

4.  Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease.

Authors:  S K Singhrao; J W Neal; B P Morgan; P Gasque
Journal:  Exp Neurol       Date:  1999-10       Impact factor: 5.330

5.  Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement.

Authors:  N J Scolding; B P Morgan; W A Houston; C Linington; A K Campbell; D A Compston
Journal:  Nature       Date:  1989-06-22       Impact factor: 49.962

6.  Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes.

Authors:  P Gasque; P Chan; M Fontaine; A Ischenko; M Lamacz; O Götze; B P Morgan
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

7.  Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies.

Authors:  P Vanguri; C L Koski; B Silverman; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

8.  Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture.

Authors:  J P Bolaños; S J Heales; J M Land; J B Clark
Journal:  J Neurochem       Date:  1995-05       Impact factor: 5.372

9.  Control of the amplification convertase of complement by the plasma protein beta1H.

Authors:  J M Weiler; M R Daha; K F Austen; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

10.  The expression of CD59 in normal human nervous tissue.

Authors:  C Vedeler; E Ulvestad; L Bjørge; G Conti; K Williams; S Mørk; R Matre
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

View more
  40 in total

1.  CD55 expression patterns on intestinal neuronal tissue are divergent from the brain.

Authors:  K A Gelderman; H J M A A Zijlmans; M J Vonk; A Gorter
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

Review 2.  Complement in neuroprotection and neurodegeneration.

Authors:  Vijay Yanamadala; Robert M Friedlander
Journal:  Trends Mol Med       Date:  2010-01-28       Impact factor: 11.951

Review 3.  [The relevance of the inflammatory response in the injured brain].

Authors:  O I Schmidt; I Leinhase; E Hasenboehler; S J Morgan; P F Stahel
Journal:  Orthopade       Date:  2007-03       Impact factor: 1.087

4.  Oxidative stress and the regulation of complement activation in human glaucoma.

Authors:  Gülgün Tezel; Xiangjun Yang; Cheng Luo; Angela D Kain; David W Powell; Markus H Kuehn; Henry J Kaplan
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-19       Impact factor: 4.799

5.  Complement Component C3 Promotes Cerebral Ischemia/Reperfusion Injury Mediated by TLR2/NFκB Activation in Diabetic Mice.

Authors:  Zheng Lin; Haoran Lin; Wenlu Li; Yuwen Huang; Haibin Dai
Journal:  Neurochem Res       Date:  2018-06-13       Impact factor: 3.996

6.  Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues.

Authors:  Yuhsuke Ohmi; Orie Tajima; Yuki Ohkawa; Atsushi Mori; Yasuo Sugiura; Keiko Furukawa; Koichi Furukawa
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-11       Impact factor: 11.205

Review 7.  The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host's Defense Strategy against Neuroinflammation.

Authors:  Yosra Bedoui; Jim W Neal; Philippe Gasque
Journal:  J Neuroimmune Pharmacol       Date:  2018-06-16       Impact factor: 4.147

8.  Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice.

Authors:  Denise Harhausen; Uldus Khojasteh; Philip F Stahel; B Paul Morgan; Wilfried Nietfeld; Ulrich Dirnagl; George Trendelenburg
Journal:  J Neuroinflammation       Date:  2010-03-04       Impact factor: 8.322

9.  Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury.

Authors:  Ying Wang; Yansong Li; Shawn L Dalle Lucca; Milomir Simovic; George C Tsokos; Jurandir J Dalle Lucca
Journal:  J Neuroinflammation       Date:  2010-04-09       Impact factor: 8.322

10.  The role of the complement system and the activation fragment C5a in the central nervous system.

Authors:  Trent M Woodruff; Rahasson R Ager; Andrea J Tenner; Peter G Noakes; Stephen M Taylor
Journal:  Neuromolecular Med       Date:  2009-09-11       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.